ABOUT US
OUR STORY
In 2013, the Biomaterials and Bioengineering Laboratory of the French National Institute for Health and Medical Research (Inserm UMR 1121), co-directed by our CSO, Dr. Philippe LAVALLE, discovered the antimicrobial properties of the anti-inflammatory coatings we were working on.
Between 2016 and 2018, we worked to develop our technology with the support of SATT Conectus .
In 2019, our CEO, Dr. Nihal Engin VRANA, together with 2 collaborators, Dr. Philippe LAVALLE and Dr. Angela MUTSCHLER created SPARTHA Medical and were then incubated at SEMIA.
TEAM UP
To date, the team has expanded with a production manager, Ms. Cynthia CALLIGARO; a Business Developer, Dr. Pulchérie MATSODOUM and a CFO, M. Thierry MIGNOT.
We are also privileged to have a multidisciplinary and experienced scientific advisory board.
OUR TEAM
Scientific Advisory Board
Strategic Advisory Board
Prof. Pierre Schaaf
University of Strasbourg
Co-inventor \ Surface chemistry Expert
Prof. Ghaemmaghami
University of Nottingham
Clinical Immunology Expert
Prof. Florent Meyer
University of Strasbourg
Periodontal Surgeon
Severine Sigrist
CEO Defymed
Class III Medical device developper \ Reglementation
Guillaume Vetter Genoud
Director of Deep Tech
SEMIA (Finance)
Agnès Dupret-Bories
Chief Surgeon UITC
clinical trials
OUR PARTNERS
RESEARCH SUPPORTS
TerminAnion Project
Unité de recherche UMR S1110
Institut de Recherche sur les Maladie Virales et Hépatiques
For more Informations : CONTACT US